Mangalam Drugs And Organics Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 15.83 Cr
as on 17-07-2024
- Company Age 52 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 352.86 Cr
as on 17-07-2024
- Satisfied Charges ₹ 199.30 Cr
as on 17-07-2024
- Revenue -17.39%
(FY 2023)
- Profit -93.54%
(FY 2023)
- Ebitda -47.98%
(FY 2023)
- Net Worth 0.93%
(FY 2023)
- Total Assets 9.50%
(FY 2023)
About Mangalam Drugs And Organics
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532637 and on the National Stock Exchange(NSE) under MANGALAM.
The Corporate was formerly known as Mangalam Drugs And Organics Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 15.83 Cr.
The company currently has active open charges totaling ₹352.86 Cr. The company has closed loans amounting to ₹199.30 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mangalam Drugs And Organics Limited India are Jayant Barde as COMPANY SECRETARY and Ajay Samant as Cfo. Praveen Saxena, Govardhan Dhoot, Rakesh Milwani, and Three other members serve as directors at the Company.
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Mangalam Drugs And Organics Limited offer?
Mangalam Drugs And Organics Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, HIV Drugs, Pharma Ingredients & Raw Materials, Anti Infective API, Antipyretic and Analgesic API, Flavours & Aromatics, Food Acidulant, Brain & Nervous System Drugs, Psychotherapeutic Agents, Vitamin Powder API.
Who are the key members and board of directors at Mangalam Drugs And Organics?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Govardhan Dhoot  | Managing Director | 16-Apr-1996 | Current |
| Jayant Barde | Company Secretary | 08-Feb-2022 | Current |
| Ajay Samant | CFO | 31-Oct-2014 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakesh Milwani | Director | 10-Mar-2022 | Current |
| Praveen Saxena | Director | 21-Mar-2021 | Current |
| Brijmohan Dhoot | Whole-Time Director | 02-May-2015 | Current |
| Nidhi Mundada | Director | 28-May-2018 | Current |
| Rukmesh Dhandhania | Director | 20-Nov-2017 | Current |
Financial Performance and Corporate Structure Insights of Mangalam Drugs And Organics.
Mangalam Drugs And Organics Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.39% decrease. The company also saw a substantial fall in profitability, with a 93.54% decrease in profit. The company's net worth moved up by a moderate rise of 0.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mangalam Drugs And Organics?
In 2023, Mangalam Drugs And Organics had a promoter holding of 50.31% and a public holding of 49.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Elarci (Estates And Constructional) Development Servicespvt LtdActive 39 years 7 months
Brijmohan Dhoot is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 13 Oct 2023 | ₹1.01 M | Open |
Hdfc Bank Limited Creation Date: 29 Aug 2023 | ₹1.16 M | Open |
Hdfc Bank Limited Creation Date: 12 Jul 2022 | ₹45.00 Cr | Open |
How Many Employees Work at Mangalam Drugs And Organics?
Mangalam Drugs And Organics has a workforce of 453 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mangalam Drugs And Organics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mangalam Drugs And Organics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
